New Sensor May Allow Earlier Diagnosis of Alzheimer's
the Psychiatry Advisor take:
A new sensor offers a novel method of testing for diseases like Alzheimer's and therefore may speed diagnosis, according to an article published in Shiny Shiny.
Diseases cause antigens to appear in the blood. Scientists can detect a disease's presence by checking the reaction of blood molecules against antibodies. This process has traditionally been lengthy and complex due to the need for a large sample size and analysis by fluorescent probes. This new sensor makes the process much simpler.
The device has a semiconductor image sensor that can detect disease markers in a small drop of blood or urine. The scientists, from Toyohashi University of Technology and the National Centre for Geriatrics and Gerontology in Japan, have successfully used the device to identify amyloid beta-peptide, an indicator of Alzheimer’s disease. Usually, Alzheimer’s disease is not diagnosed until symptoms occur, and by this time it is too late for intervention. Earlier detection allows for earlier initiation of treatment that could halt or slow disease progression.
In addition to being quicker than standard systems, the new device is smaller, easier to use, and inexpensive.
The device should be able to detect any disease for which blood markers have already been identified, so the device has potential to spot a multitude of disease other than Alzheimer’s, from cancer to Parkinson’s.
A new Alzheimer's test can detect the disease with only a drop of blood or urine.
Psychiatry Advisor Articles
- Low-Dose Dexmedetomidine Reduces Postoperative Delirium in Older Patients
- Lithium Side Effects for Bipolar Disorder Lead to Lower Prescription Rates
- First-Episode Schizophrenia Approaches Aided by Guidelines Instrument
- Predictors of Favorable Outcomes in First-Episode Psychosis Without Medication
- Facebook Addiction Associated With Social Insecurity
- Suicide Prevention and Intervention: Cross-Cultural Perspectives
- Antipsychotic Switching in Schizophrenia: Immediate vs Gradual Discontinuation
- Bipolar Disorder Monotherapy Treatment Approved
- Slightly Higher HIV Screening in Patients With Severe Mental Illness
- Treating Pain in Depression May Improve Cognitive, Functional Outcomes